Meet Our Team
tVNS® E is currently the only transcutaneous, non-invasive vagus nerve stimulation device approved in Europe under the new Medical Device Regulation.
tVNS® E is explicitly approved for the indications of epilepsy, chronic migraine, depression, and Prader-Willi syndrome.
Reduction in seizure frequency over a 28-day period during the intervention compared with the phase before the intervention by at least 25% after 20 weeks of treatment.
Reduction in seizure frequency over a 28-day period during the intervention compared with the phase before the intervention by at least 25% after 20 weeks of treatment.
Reduction in seizure frequency over a 28-day period during the intervention compared with the phase before the intervention by at least 25% after 20 weeks of treatment.
Reduction in seizure frequency over a 28-day period during the intervention compared with the phase before the intervention by at least 25% after 20 weeks of treatment.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
tVNS® has already been featured in numerous renowned national and international health science, and innovation media outlets for it’s evidence-based approach to non-invasive vagus nerve stimulation. The coverage underlines the growing medical-stimulation interest in transcutaneous vagus nerve stimulation and the importance of clinically sound technology certified according to the European Medical Device Regulation (MDR).
Click the publications logo that you would like to see, or scroll below and click on the article you would like to read.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Safety and frequently asked questions about transcutaneous vagus nerve stimulation (tVNS®) Transcutaneous vagus nerve stimulation is a non-invasive, well-tolerated method that has been used for several years in medical research and practice. Nevertheless, questions about safety and application understandably arise. The most important answers are provided here.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
Yes. tVNS® is generally used as an add-on therapy and can be combined with medication, psychotherapy, or other treatment forms. However, changes to existing therapies should always be discussed with the treating clinician.
